1.24
price down icon2.36%   -0.03
after-market アフターアワーズ: 1.15 -0.09 -7.26%
loading

Lyell Immunopharma Inc (LYEL) 最新ニュース

pulisher
09:31 AM

Lyell Announces Presentation of Initial Clinical Data from - GlobeNewswire

09:31 AM
pulisher
09:30 AM

Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting - StockTitan

09:30 AM
pulisher
03:42 AM

Vanguard Group Inc's Strategic Reduction in Lyell Immunopharma I - GuruFocus.com

03:42 AM
pulisher
Nov 03, 2024

Lyell shares down as BofA double downgrades to Sell - MSN

Nov 03, 2024
pulisher
Nov 03, 2024

Lyell Immunopharma (NASDAQ:LYEL) Downgraded to “Underperform” Rating by Bank of America - Defense World

Nov 03, 2024
pulisher
Oct 31, 2024

Lyell Immunopharma Completes Acquisition of ImmPACT Bio - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Lyell Immunopharma acquires ImmPACT Bio to boost CAR T-cell therapy - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

B of A Securities Downgrades Lyell Immunopharma (LYEL) - MSN

Oct 31, 2024
pulisher
Oct 31, 2024

Lyell Immunopharma’s (LYEL) “Neutral” Rating Reiterated at HC Wainwright - Defense World

Oct 31, 2024
pulisher
Oct 30, 2024

Lyell Immunopharma Downgraded, Analyst Flags Concerns Over Acquisition Strategy - Benzinga

Oct 30, 2024
pulisher
Oct 30, 2024

Lyell shares down as BofA double downgrades to Sell By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Lyell cut to underperform by BofA, pipeline reorganization cited - MSN

Oct 30, 2024
pulisher
Oct 30, 2024

Lyell Immunopharma (NASDAQ:LYEL) Lowered to Underperform Rating by Bank of America - MarketBeat

Oct 30, 2024
pulisher
Oct 28, 2024

HC Wainwright Reiterates Neutral Rating for Lyell Immunopharma (NASDAQ:LYEL) - MarketBeat

Oct 28, 2024
pulisher
Oct 27, 2024

Lyell Immunopharma’s Acquistion of ImmPACT Bio USA - Global Legal Chronicle

Oct 27, 2024
pulisher
Oct 25, 2024

Lyell Will Seek To Improve On Existing CAR-Ts Via Merger With ImmPACT - Citeline News & Insights

Oct 25, 2024
pulisher
Oct 25, 2024

Lyell Immunopharma stock hits 52-week low at $1.05 By Investing.com - Investing.com Australia

Oct 25, 2024
pulisher
Oct 25, 2024

Lyell goes all in on CAR-T therapies, buys ImmPACT Bio and trims pipeline - Pharmaceutical Technology

Oct 25, 2024
pulisher
Oct 25, 2024

Lyell Immunopharma stock hits 52-week low at $1.05 - Investing.com

Oct 25, 2024
pulisher
Oct 25, 2024

Lyell Immunopharma: Oversold And Poised For A Turning Point To Growth (NASDAQ:LYEL) - Seeking Alpha

Oct 25, 2024
pulisher
Oct 24, 2024

Lyell, in search of a turnaround, to buy cell therapy startup ImmPact - BioPharma Dive

Oct 24, 2024
pulisher
Oct 24, 2024

Lyell boosts pipeline with ImmPACT acquisition - Investing.com India

Oct 24, 2024
pulisher
Oct 24, 2024

Lyell Immunopharma to Buy ImmPact; Refocuses Pipeline on T-Cell Cancer Treatments - MarketWatch

Oct 24, 2024
pulisher
Oct 24, 2024

Lyell Immunopharma to acquire ImmPACT Bio (NASDAQ:LYEL) - Seeking Alpha

Oct 24, 2024
pulisher
Oct 24, 2024

Lyell boosts pipeline with ImmPACT acquisition By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies - StockTitan

Oct 24, 2024
pulisher
Oct 15, 2024

Lyell Immunopharma Inc (LYEL) deserves deeper analysis - US Post News

Oct 15, 2024
pulisher
Oct 14, 2024

The Manufacturers Life Insurance Company Grows Stock Holdings in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Oct 14, 2024
pulisher
Oct 13, 2024

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Large Decline in Short Interest - MarketBeat

Oct 13, 2024
pulisher
Oct 10, 2024

Lyell Immunopharma Inc (LYEL Stock: A Sea of Opportunity - The InvestChronicle

Oct 10, 2024
pulisher
Oct 09, 2024

Lyell Immunopharma stock hits 52-week low at $1.09 - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

Lyell Immunopharma stock hits 52-week low at $1.09 By Investing.com - Investing.com UK

Oct 09, 2024
pulisher
Oct 08, 2024

ProShare Advisors LLC Cuts Stake in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Oct 08, 2024
pulisher
Oct 04, 2024

Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - The Manila Times

Oct 04, 2024
pulisher
Oct 04, 2024

Lyell Immunopharma Announces the Acceptance Abstracts for - GlobeNewswire

Oct 04, 2024
pulisher
Oct 03, 2024

An analyst sees good growth prospects for Lyell Immunopharma Inc (LYEL) - SETE News

Oct 03, 2024
pulisher
Oct 02, 2024

XTX Topco Ltd Has $102,000 Stock Holdings in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

Lyell Immunopharma Inc (LYEL) Stock: A Year of Declines and Increases - The InvestChronicle

Oct 01, 2024
pulisher
Sep 30, 2024

LYEL underperforms with a -0.66 decrease in share price - US Post News

Sep 30, 2024
pulisher
Sep 27, 2024

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Shares Sold by Rhumbline Advisers - Defense World

Sep 27, 2024
pulisher
Sep 26, 2024

The Significance of Moving Averages in Lyell Immunopharma Inc Inc. (LYEL) Price Performance - The InvestChronicle

Sep 26, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):